Should combined pharmaco- and psychotherapy be offered to depressed patients?: A qualitative review of randomized clinical trials from the 1990s

European Archives of Psychiatry and Clinical Neuroscience

Volumn 254, Issue 2, 2004, Pages 99-107

  Hegerl, Ulrich ^a   Plattner, Anita ^a   Möller, Hans Jürgen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antidepressants; Depression; Psychotherapy

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; IMIPRAMINE; NEFAZODONE; NORTRIPTYLINE;

BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG BLOOD LEVEL; HUMAN; LONG TERM CARE; MAJOR DEPRESSION; META ANALYSIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; METHODOLOGY; MULTIMODALITY CANCER THERAPY;

ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; HUMANS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 2642514251     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-004-0490-5     Document Type: Review

References (24)

1. American Psychiatric Association (1993) Practice guidelines for major depressive disorder in adults. Am J Psychiatry 150:1-26
2. Beitman BD, Klerman GL (1991) Integrating Pharmacotherapy and Psychotherapy. Washington, DC: APA
3. Clarke M, Oxman AD (2001) Cochrane Reviewers Handbook 411. The Cochrane Library, issue 1. Oxford: Update Software
4. Conte HR, Plutchik R, Wild KV, Karasu TB (1986) Combined psychotherapy and pharmacotherapy for depression. A systematic analysis of the evidence. Arch Gen Psychiatry 43:471-479
5. de Jong-Meyer R, Hautzinger M, Rudolf GAE (1996) The effectiveness of antidepressants and cognitive-behavioral therapy, combined in patients with endogenous depression: Results of analyses of variance regarding main and secondary outcome criteria. Z Klin Psychol 25:93-109
6. Depression Guideline Panel (1993) Depression in primary care 2: Treatment of major depression. Clinical Practice Guideline No 5; AHCPR Publication No 93-0551, Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research
7. Elkin I, Shea MT, Watkins JT (1989) National Institute of Mental Health Treatment of Depression Collaborative Research Program: General effectiveness of treatments. Arch Gen Psychiatry 46:971-982
8. Frank E, Kupfer DJ, Perel JM (1990) Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47:1093-1099
9. Gaffan EA, Tsaousis I, Kemp-Wheeler WS (1995) Researcher allegiance and meta-analysis: the case of cognitive therapy for depression. J Consult Clin Psychol 63:966-980
10. Hautzinger M, de Jong-Meyer R, Treiber R (1996) Effectiveness of cognitive behavior therapy, pharmacotherapy, and the combination of both in nonendogenous unipolar depression. Z für Klin Psychol 25:130-145
11. Hollon SD, Shelton RC, Loosen PT (1991) Cognitive therapy and pharmacotherapy for Depression. J Consult Clin Psychol 59: 88-99
12. Hollon SD, DeRubeis RJ, Evans MD (1992) Cognitive therapy and pharmacotherapy for depression singly and in combination. Arch Gen Psychiatry 49:774-781
13. Keller MB, Harrison W, Fawcett JA (1995) Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacol Bull 31:205-212
14. Keller MB, McCullough JP, Klein (2000) A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342:1462-1470
15. Kupfer DJ (1991) Five Possible Change Points During Treatment: Response, Remission, Relapse, Recovery, Recurrence, Fig. adapted from Lessons to be learned from long-term treatment of affective disorders: Potential utility in panic disorder. J Clin Psychiatry, p. 13
16. Lima MS, Moncrieff JA (2000) Comparison of drugs versus placebo for the treatment of dysthymia (Cochrane Review). The Cochrane Library, issue 1. Oxford, Update Software
17. Mueller TI, Leon AC, Keller MB (1999) Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 156:1000-1006
18. Oxman AD, Cook DJ, Guyatt GH (1994) For the Evidence-Based Medicine Working Group: User's Guides to the Medical Literature VI How to use and overview. JAMA 272:1367-1371
19. Paykel ES, Scott J, Teasdale JD (1999) Prevention of relapse in residual depression by cognitive therapy. A controlled trial. Arch Gen Psychiatry 56:829-835
20. Reynolds CF, Frank E, Perel JM (1999) Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 281:39-45
21. Robinson LA, Berman JS, Neimeyer RA (1990) Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research. Psychol Bull 108:30-49
22. Sackett DL (1998) Evidence-based medicine. Spine 15:1085-1086
23. Thase ME (1999) When are psychotherapy and pharmacotherapy combinations the treatment of choice for major depressive disorder? Psychiatry Quarterly 70:333-346
24. Thase ME, Greenhouse JB, Frank E (1997) Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 54:1009-1015